Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-01-12

Clinical Trial Update: Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery

View source ↗

Summary

A clinical trial update evaluating the safety profile of rivaroxaban for venous thromboembolism prophylaxis after hip fracture surgery. The current trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (Xarelto) (rivaroxaban)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Open Fracture of Hip | Status: UNKNOWN